Introductory Chapter: The Newest Research in Quinazolinone and Quinazoline Derivatives by Al-kaf, Ali Gamal
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Introductory Chapter: The Newest 
Research in Quinazolinone and 
Quinazoline Derivatives
Ali Gamal Al-kaf
1. Introduction
Target searching for new high effective medicinal preparation is considered one 
of the actual problems of the modern public health. From medicinal preparations 
are the natural and synthetic origins of quinazolinone-4 derivatives. Quinazolinone 
derivatives are reported to be physiologically and pharmacologically active [1].
They also exhibit a wide range of activities such as anticonvulsant, anti-
inflammatory, antifungal, antimalarial, and sedative. Some of these compounds are 
identified as drugs used as diuretics, vasodilators, and antihypertensive agents.
Moreover, sulfonamide derivatives have been widely used as bacteriostatic 
agents. Prompted by the abovementioned facts and in conjunction with our ongo-
ing program on the utility of readily obtainable starting material for the synthesis of 
heterocyclic systems of biological interest, we have decided to synthesize a series of 
quinazolinone derivatives having sulfonamide moiety with potentially wide spec-
trum of biological responses [2, 3]. Information about the biological properties of 
derivatives of quinazolinone before the end of 60-years ago was more fragmentary.
At the end of 40 years, an alkaloidal compound febrifugin (dichroin) 3-[β-keto-
γ(3-oxipiperidine-2) propyl] quinazolone-4 was isolated from Chinese plant 
Chang-Shan (Dichroa febrifuga Laur.) and has antimalarial activity, 100 times 
greater than quinine. This compound has not found clinical application, since it is 
300 times toxic than quinine alkaloids [4, 9, 10, 21] (Figure 1).
However, work with febrifugin encouraged further searching for new biologi-
cally active compounds among the derivatives of quinazolinones-4 [4].
Already, on early stages of the studies, chemotherapeutic, anti-inflammatory 
activity, and hypnotic and hypotensive actions were revealed [5].
Sixty to seventy years ago, more than 300 patents appeared in different coun-
tries, denoted synthesis and study of biological activity of this type of compounds. 
More than 20 medicinal preparations (analgesic, sedative, diuretic, hypotensive, 
Figure 1. 
The structure of the compound febrifugin (dichroin).
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cholegogue, bronchodilator, tranquilizer, chemotherapeutic action) of quinazoline 
derivatives are introduced in medicinal practice [5–7].
Among various quinazolinone derivatives, big attention was attracted to the 
substituted-(3Н) quinazolinones-4, which show the significant hypnotic activity [4].
2-Methyl-3-(o-tolyl) quinazolinone-4, named methaqualone, is broadly used 
in medicinal practice [5, 8] as sedative and hypnotic. Aside from hypnotic action, 
methaqualone possesses the anticonvulsant and anti-cough properties and intensi-
fies the action of barbiturates, analgesics, and neuroleptics [7].
The high activity and small toxicity of methaqualone were a motivation for 
study of the large number of its analogues [9] (Figure 2).
Similar analogues of methaqualone such as—a light hypnotic ethaqualone, as 
well as mecloqualone which is used in medicine as hypnotic and sedative [4, 10].
2-Methyl-3-(o-cyan phenyl) quinazolone-4 is characterized by the highest 
hypnotic, sedative, and anticonvulsant activity [11]. Strong psychotropic action is 
showed in triflourmethyl analogue of methaqualone [12].
The series analogues of methaqualone with similar pharmacological properties 
with ortho-substiuted have an alkyls or other functional groups and in the other 
positions phenyl residues [4, 13].
Among compounds of this group, the most popular compounds that have 
been used in practical medicine are 2-methyl-З-(o-methyl-p-chlorphenyl)-
5-chlorquinazolone-4 (SL-I64) as tranquilizer and 2-methyl-3-(о-methoxy-
p-nitrophenyl) quinazolone-4 (nitromethaqualone) as hypnotic [14]. 
Quinazolinones-4 render also hypothermic and spasmolytic action [5].
At study of more than 40 derivatives of quinazolines, some qualitative correla-
tions between structure and convulsive activity were revealed [15, 16]. Transition 
from 3-aryl- to 3-alkylquinazolones-4 saves the sedative, hypnotic, and anticonvul-
sant properties of compounds [16]. The last type of activity is also characterized for 
2-methyl-3-piperazino-alkylquinazolones-4.
Variation of the substituted in position 3 may affect upon biological properties 
of substances in these compounds. So, 3-cyanalkyl-quinazolones-4, for example, 
are diuretics, but corresponding to aminoketones and aminohydroxy, derivatives 
show analgesic, spasmolytic, and anti-inflammatory activities [4].
Derivatives of (1Н)-quinazolinones-4 are less studied. For them, the most 
characterized properties are analgesic, anti-cough, and anti-inflammatory 
activity [10, 17]. 1,2,3,4-Tetrahydroquinazolones-4 were studied greatly in 
details.
Some compounds of this line, unsubstituted in position 1, show the antibac-
terial and cytostatic activities. 1-Alkyl or aryl derivatives are characterized as 
anti-inflammatory, bronchodilator, and sedative action; 1-dialkylaminoalkyl- and 
1-acyl, including substituted aminoacyl-1-tetrahydroquinazolones-4, have mani-
fested themselves as analgesics and tranquilizers, myorelexants, and diuretics. 
Figure 2. 
The structures of methaqualone and its analogues.
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Significantly, their parts described antihistamine, cholagogue, and anti-inflamma-
tory properties [10].
N-Heteril derivatives of quinazolinone-4, containing of fragments of antipyrin 
and thiazole in the position 3, have anti-hypoxic activity [18].
Anagrelide is a quinazoline compound, possessing anti-thrombocyte aggrega-
tion activity [19]. Quinazoline-derived doxazosin and terazosin (α1-adrenoreceptor 
antagonists) show the highest activity in the cancer of the prostate gland [19, 20].
Mokvizon [21] has been found to be used in practical medicine as cholagogue 
and hypocholesterolemic remedy (Figure 3).
Among 3-alkyliden-1,2.3,4-tetrahydroquinazolones-4, glycozine was used as 
preparation of hypnotic action.
Introduction of chlorine in position seven and sulfamide group in position six 
of quinazolines-4 brings the high active diuretics and saluretics of the chlorothia-
zide type. Diuretic action of the substances increases when they are turning from 
quinazolones-4 to tetrahydroquinazolones [9].
Compounds, for example, of this type are metolazone, SR 720-22, zaroxoline, 
quinethazone, hydromox, and others. They are introduced into medicinal practice 
as diuretics and saluretics [4].
Pharmacological screening has allowed revealing the sedative activity for some 
derivatives of quinazolinone-4:
4-(2-Phenyl-4-oxoquinazolil) –butyric acid increases the duration of nembutalic 
sleep in comparison with control on 106% [22, 23] and influences upon parameters 
of hemodynamic system of awake rats [24–26].
Derivatives of quinazoline-4(3Н)-one show antimicrobial, antifungal, antima-
larial, antituberculosic, antihypertensive activity, as well as anticonvulsant and 
sedative actions [27–30].
The pharmacological studies found that the most activity, that these compounds 
have 2′, 4′-dimethoxyphenyl radical at position 2 of quinazolone cycle.
So, the most anti-inflammatory activity is characterized by 1-acetyl-2-(2′, 
4′-dimethoxyphenyl)-3-[(4-methoxyphenyl) or (4-chlorphenyl)]-1,2,3, 
4-tetrahydroquinazolinones-4.
High anticonvulsant activity was shown in 1-adamantilacetyl-2-(2′,4′-dimethox
yphenyl)-3-benzyl-1,2,3,4-tetrahydroquinazolinone-4 [27].
Figure 3. 
The structures of mokvizon and glycozine.
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2-Styril-4-aminoquinazolinones are characterized by strong activity in respect 
of gram-positive bacteria, Mycobacterium tuberculosis, pathogenic proterozoic infec-
tion, pathogenic viruses, and fungi [30].
Pharmacological screening of some derivatives of quinazolinone-4 has allowed 
revealing for analeptic, anti-inflammatory, and anti-hypoxic activity and slightly 
toxic:
4-Amino-4′-[2-phenyl-4-oxoquinazoline-3]-diphenylsulfone (QPhD) and 
4,4’-bis-[2-phenyl-4-oxoquinazoline-3]-diphenylsulfone (BisQPhD) have analep-
tic, anti-inflammatory, and anti-hypoxic activities and are slightly toxic [21, 31].
In one study 4-amino-4′-[2-phenyl-4-oxoquinazoline-3]-diphenylsulfone 
(QPhD) shows strong immunotropic activity surpassing the comparing drug 
methyluracil [32].
In one study 4-(4-Oxo-2-phenyl-4H-quinazolin-3-yl)-N-pyrimidin-2-yl-
benzenesulfonamide (Compound A) and N-(4,6-Dimethyl-pyrimidin-2-yl)-4-
(4-oxo-2-phenyl-4H-quinazolin-3-yl)-benzenesulfonamide (Compound B) show 
strong hepatoprotective and antioxidant activity surpassing the comparing drug 
Liv-52 [33].
Accessibility of quinazoline derivatives and versatility of their biological 
activity attract well-earned attention to similar class of substances. The similar-
ity is not only physicochemical properties of pyrimidine and quinazolinone, 
but also spectrum of biological activity opens the new possibilities for search-
ing for high active compounds in these class substances [10, 34]. The extensive 
array of information, denoted synthesis, and study of the biological activity 
of derivatives of quinazolinon-4 is indicative of exclusive possibility of the 
synthesis of new biologically active compounds. Synthesis of 4-(4-oxo-2-phenyl-
4H-quinazolin-3-yl)-N-pyrimidin-2-yl-benzenesulfonamide (Compound A) 
and N-(4,6-dimethyl-pyrimidin-2-yl)-4-(4-oxo-2-phenyl-4H-quinazolin-3-yl)-
benzenesulfonamide (Compound B) showed high antimalarial activity compared 
with chloroquin [35].
The synthesis of 4-(4-oxo-2-phenyl-4H-quinazolin-3-yl) benzene sulfon-
amide (Compound A) and N-acetyl-4-(4-oxo-2-phenyl-4H-quinazolin-3-yl)-
benzenesulfonamide (Compound C) having analgesic and anti-inflammatory 
activities but Compound C showed a significant activity than Compound A; also 
the Compound A has a pharmacological activity more significant than standard 
drug diclofenac. Further studies are important to ensure their analgesic and anti-
inflammatory mechanisms.
The docking study explains the inhibitory effect of the A and C compounds 
against the in vivo anti-inflammatory and analgesic activity. The compounds A and 
C have similar effect as diclofenac and indomethacin reference drugs in the in vivo 
anti-inflammatory and analgesic activity [36].
Synthesis of 4-(4-oxo-2-phenyl-4H-quinazolin-3-yl)-N-pyrimidin-2-yl-benzene 
sulfonamide (Compound B) and N-(4,6-dimethyl-pyrimidin-2-yl)-4-(4-oxo-2-
phenyl-4H-quinazolin-3-yl)-benzene sulfonamide (Compound D) gave a Pa < 0.5 
as nootropic by the PASS program, but experiments on animals confirmed the anti-
hypoxic activity of the compounds, which means they might occur as new chemical 
entities. Compound D has shown the strongest anti-hypoxic activity. A docking 
study of the synthesized derivatives with GluA3 confirmed the result in vitro and 
revealed that Compound D is an anti-hypoxic agent [37].
Our aim is to focus on all the methods for synthesis and different interesting 
biological activities of quinazolinone and quinazoline derivatives.
Our major objective of this project is to give the information in a lucid, con-
densed, and cohesive form and to specially cater the needs of readers in medicine 
and pharmacy.
5Introductory Chapter: The Newest Research in Quinazolinone and Quinazoline Derivatives
DOI: http://dx.doi.org/10.5772/intechopen.88913
Author details
Ali Gamal Al-kaf
Medicinal Chemistry Department, Faculty of Pharmacy, Sana’a University, Sana’a, 
Yemen
*Address all correspondence to: alialkaf21@gmail.com
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
6Quinazolinone and Quinazoline Derivatives
[1] Pojarsky AF. Theoretical principles 
of heterocyclic chemistry. Chemistry. 
1985:276
[2] Ram VJ, Tripathi BK, Srivastava AK. 
Bioorganic & Medicinal Chemistry. 
2003;11:2439
[3] Dandia A, Singh R, Sarawgi P. 
Synthesis of some Annelated 
Quinazoline Derivatives. The Journal 
of the Chinese Chemical Society. Vol. 
445. China, Taipei: Wiley-VCH & The 
Chemical Society. 2005. p. 307
[4] Vizgunova OL, Kojevnicov UV, 
Obvinseva LM, Zalesov VS. Study 
amongst quinazolinone-4. 
XVII. Synthesis and biological 
activity of 1, 2- disubstituted 
of quinazolinone-4. Chemical-
The Pharmaceutical Journal. 
1985;33(11):1047-1049
[5] Morgaluk VP et al. Synthesis 
and cardiotonic activity derivatives 
of 6, 7-dimethoxyquinazoline. 
Chemical-Pharmaceutical Journal. 
1991;25(1):28-32
[6] Kang-Chien L, Ji-Wang C. Synthesis 
and antihypertensive activity of 
some fused quinazoline derivatives. 
Heterocycles. l984;21:503
[7] Mashkovskiy MD. The Medicinal 
Remedies. Vol. 2. Kharkov: Torsing; 
1997. p. 592
[8] Wilson and Gisvold’s. Textbook 
of Organic Medicinal and 
Pharmaceutical Chemistry. 10th ed. 
New York: Lippincott Raven; 1998. 
p. 446
[9] Chernobrovin NE, Kojevnicov UV, 
Bobrovskaya OV, Siropchtov BYA. 
Synthesis and biological activity 
of 1-acetyl-2,3-diaryl-1,2,3,4-
tetrahydroquinazolinones-4. 
Chemical The Pharmaceutical Journal. 
1999;30(11):40-44
[10] Yahontov LN, Liberman SS, 
Jihareva GP, Kuzmin KK. Biological 
activity of quinazoline derivatives. 
Chemical-Pharmaceutical Journal. 
1977;11:14-26
[11] Ribuhin UE. Salts of 4 
(5Н)-oxazolonium, 4-oxo-1,3-
oxazinonium and its hetero-analogues. 
[D.Sc. Thesis, doctor of chemical 
sciences]. Rostov-Na Danu; 1991. 
pp. 184-187
[12] Kojevnicov UV, Smirnov NN, 
Zalesov VS, Gradel EE. Study amongst 
4[3h] quinazolone. X. Synthesis 
of biological activity of 
perchlorates 1-ethyl-2-methyl-
3-aryl-4[3h] quinazolonium. 
Chemical-Pharmaceutical Journal. 
1981;12(6):55-59
[13] Yahontov LN et al. Synthesis 
and study of biological activity 
of substituted 4-amino-2-
styrylquinazolines. Chemical-
Pharmaceutical Journal. 
1975;9(11):12-18
[14] Martindale: The Extra 
Pharmacopoeia. 30th ed. Vol. 3750. 
London: Pharmaceutical Press; 1993
[15] Kojevnicov UV, Smirnov NN, 
Zalesov VS, Gradel EE. Study amongst 
4[3h] quinazolone. X. Synthesis 
and biological activity of 
perchlorates 1-ethyl-2-methyl-
3-aryl-4[3h] quinazolonium. 
Chemical-Pharmaceutical Journal. 
1981;12(6):55-59
[16] Bakibaev AA et al. Synthetic 
anticonvulsants, anticonvulsants 
and inductors of monoxygenase 
system of the liver on the bases 
of amides and urea. V. Synthesis 
and biological activity of new 
derivatives of ortho—substituted 
benzylhydrilurea—Potential syntones 
for quinazolines and benzazepines. 
References
7Introductory Chapter: The Newest Research in Quinazolinone and Quinazoline Derivatives
DOI: http://dx.doi.org/10.5772/intechopen.88913
Chemical-Pharmaceutical Journal. 
1991;28(7):11-12
[17] Nogrady T. Medicinal Chemistry. 2nd 
ed. Vol. 514. New York: Oxford; 1988
[18] Oganesyan ET et al. The prediction 
and targeted synthesis of N-heterocyclic 
derivatives of quinazolinone-4. In: 
Modern High Technology Techniques. 
Vol. 6. 2004. pp. 109-110
[19] Robak T, Trelinski J, Holub A. 
Anagrelide-new anti-platelet drug. 
Acta Haematologica Polonica. 
1994;25(4):309-315
[20] Drug Information for the Health 
Care Professional. 22nd ed. Vol. 1. 
New York; 2002. p. 3291
[21] Castle RN. Condensed Pyridazines 
Including Chinnolines and Phthalazines. 
Vol. 98. New York: Wiley-Interscience; 
1973
[22] Kodonidi EP et al. Pharmacological 
screening of derivatives 
quinazolinone-4. Development, 
research and marketing of new 
pharmaceutical production: Scient. 
Pyatigorsk: Works collect. Of PSPA; 
2003. 58. pp. 365-367
[23] Kodonidi EP et al. Prediction 
and synthesis of derivatives of 
quinazolinone-4 with fragments of 
carbonic acids at N3 position of the 
heterocycle person and a medicine: 
Person and a medicine: Thesis of the 
10th Russian international congress 
report. 2-6 April 2003. 2003. pp. 642
[24] Kodonidi EP et al. Effect of new 
derivative of quinazolinone on the 
parameters of hemodynamic system 
in a wake rats. Development, Research 
and Marketing of New Pharmaceutical 
Production: Scient. Works Collect. 
Of PSPA. Pyatigorsk, 2003. 58. pp. 
364-365
[25] Kodonidi EP et al. Effect of new 
derivative of 4-oxopyrimidine and 
quinazolinone-4 on some parameters 
system and cerebral hemodynamic. 
Development, research and marketing 
of new pharmaceutical production: 
Scient. Pyatigorsk: Works collect of 
PSPA; 2004. 59. pp. 246-247
[26] Magonov MM. Synthesis and 
biological activity of derivatives of 
4-oxopyrimidine and quinazolinone-4 
with fragments of carbonic acids in 
nucleotide position [PhD thesis]. 
Pyatigorsk: Pharmaceutical Dep. 
Academy of Pharm; 2002. pp. 117
[27] Chernobrovin NE et al. 
Synthesis and biological activity 
of 1-acetyl-2, 3-diaryl-1,2,3,4-
tetrahydroquinazolinones-4. 
Chemical-Pharmaceutical Journal. 
1991;25(5):37
[28] Somer F et al. Original 
2-alkylamino-6-halogenoquinazolin-4 
(3H)-ones and K (ATP) channel activity. 
Journal of Medicinal Chemistry. 
2001;44(16):2575-2585
[29] Kreutzberger A, Balbach S. 
2-Guanidino-4 (3H)-quinazolinones 
with chemotherapeutic activities. Die 
Pharmazie. 1993;48(1):17-20
[30] Agrawal VK et al. QSAR studies on 
antimalarial 2,4-diamino-6-quinazoline 
sulfonamide. Department of Chemistry. 
2001;48(1):17-26
[31] Ji-Wang C, Chia-Yang S, 
Guan-Yu L. Studies on quinazolinones. 
3: Novel and efficient route to the 
synthesis of conformationally rigid 
analogues of ketanserin and SGB-
1534 as antihypertensive agents. 
Biomedical Chemistry Letters. 
1991;1:571
[32] Jihareva GP et al. Synthesis 
and chemotherapeutic study of 
2-styryl-4-(δ-diethyl amino-α-
methyl butyl amino) quinazolines. 
Chemical-Pharmaceutical Journal. 
1982;16(2):183-188
Quinazolinone and Quinazoline Derivatives
8
[33] Yassina SH, Al-kafa AG, 
Kotbb M, Abdullaha JH, 
Yahyaa TA. Antimicrobial, anti-oxidant 
and hepatoprotective activities of 
quinazolinone-4 derivatives on 
paracetamol induced hepatotoxicity 
in Guinea pigs. Journal of Natural and 
Applied Sciences. 2014;18:1
[34] Hemminki K. Ring-opened 
7-methylguanine nucleotides 
are resistant to nuclease P1 
digestion and good substrates to 
polynucleotide kinase. Carcinogenesis. 
1989;10(9):1761-1763
[35] Al-kaf A et al. Synthesis and 
antimalarial of new quinazolinone-4 
derivatives. Research in Pharmacy and 
Health Sciences. 2016;2(4):227-233
[36] Al-kaf A, Jihane A, 
Zahr BF, Rachid EJ, M’Hammed A, 
Azeddine I, et al. Synthesis, analgesic, 
antinflammatory and molecular 
docking studies of new quinazolin-
4-one derivatives. Journal Marine 
Chemistry Heterocyclic. 2017;16(1)
[37] Akachar J, Abudunia A-M, El 
Jaoudi R, Bennani FE, Ansar M, 
Ibrahimi A, et al. Synthesis, antihypoxic 
activity and molecular docking studies 
of new quinazolinone-4 derivatives. 
Journal of Science and Technology. 
2018;23:5-16
